Trusted Resources: News & Meetings
Latest announcements and gatherings
Luna and Partners Work to Accelerate Therapies for Hunter Syndrome
Advocacy organizations—the National MPS Society and Genetic Alliance—partnered with Luna to achieve this goal. In early December, we started enrolling participants in a health information-sharing and medical-discovery digital community that begins in the homes of families living with Hunter syndrome. The program is called 100 Patient Project: Unlocking MPS.
This program demonstrates a study framework where all parties are better served while enhancing research goals. This design ensures the clinical and behavioral features and key endpoints are incorporated into the drug discovery process. This can only happen when families—those who live daily with the disease and know the lived experience best—have a seat at the table as partners.
BookmarkRelated Content
-
Denali Therapeutics Announces Continued Progress in DNL310 (ETV:IDS) Program for MPS II (Hunter Syndrome) Supporting...Denali Therapeutics Inc., a biopharmaceu...
-
Evaluation of the Long-Term Treatment Effects of Intravenous Idursulfase in Patients With Mucopolysaccharidosis II (...Mucopolysaccharidosis II (MPS II; Hunter...
-
Sanfilippo Children’s Foundation – LinkedInSanfilippo Children's Foundation is a no...
-
Hunter Syndrome (MPS II): An Uncommon Combination of Childhood Complaintshttps://www.youtube.com/watch?v=7kBGEYAF...
-
Young Adults With Hunter Syndrome (MPS II)Hunter syndrome impacts many aspects of ...
-
A 1-Year and 4-Month-Old Child With Mucopolysaccharidoses Type II: A Clinical Case Report From EthiopiaMucopolysaccharidoses (MPSs) are a class...
-
Announcing Tracy Kirby, Director of DevelopmentThe National MPS Society is pleased to a...
Powered by
